 | September 1, 2011
By:Peter Houston
The time is right for industry to overcome its social media phobia once and for all.
 |
September 1, 2011
By:William Looney
Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.
|
 | May 1, 2011
By:Jerry Cacciotti, Patrick Clinton
Who's taken this year's top spot? Find out in Pharm Exec's annual run-down of the world's Top 50 pharma companies.
|
January 1, 2012
By:Bill Drummy
It's a disturbing irony: In an industry whose entire economic value is founded on its ability to innovate, why is there so much discomfort with the risk required for innovation. Where did the courage to innovate go?
|
 | January 1, 2012
By:Ben Comer
A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
|
 | January 1, 2012
By:William Looney
The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
|
 | December 1, 2011
By:Ben Comer
It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
